+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sepsis Diagnostics Market 2019-2025

  • PDF Icon

    Report

  • September 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5145112
Global Sepsis Diagnostics Market Size, Share & Trends Analysis Report by Product Type (Instruments, Assays & Reagents, and Others), By Technology (Molecular Diagnostics, Immunoassay, and Others), By Pathogen (Bacterial Sepsis Diagnostics, Fungal Sepsis Diagnostics, and Others), and Forecast 2019-2025.

The global Sepsis Diagnostics market is estimated to grow significantly during the forecast period. The primary factors that drive the growth of the market include the rising prevalence of sepsis across, rising geriatric population, and the advent of technologically advanced diagnostic solutions. Further, several government initiatives for creating sepsis awareness, and a high incidence of hospital-acquired infections are also likely to propel the sepsis diagnostics market during the forecast period. However, the lack of skilled personnel for handling diagnostics operations may hamper the growth of the market during the forecast period.

The global sepsis diagnostics market is segmented on the basis of product type, technology, and pathogen. Based on the product type, the market is segmented into instruments, assays & reagents, and other products. The assays & reagents segment is estimated to hold a significant share in the market. Based on the technology, the market is segmented into molecular diagnostics, immunoassay, and others including flow cytometry. Whereas, based on the pathogen, the market is segmented into bacterial sepsis diagnostics, fungal sepsis diagnostics, and others. Bacterial sepsis diagnostics is likely to hold a significant share in the market.

Geographically, the study of the global sepsis diagnostics market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global sepsis diagnostics market during the forecast period.

Further, Abbott Laboratories, Inc., Becton, Dickinson & Co., Biomérieux SA, Bruker Corp., Danaher Corp., F. Hoffmann-La Roche Ltd., Luminex Corp., Qiagen NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc, among others are some of the prominent players operating in the global sepsis diagnostics market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market.

Research Methodology

The market study of the global sepsis diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for pharmaceutical companies, medical device manufacturing companies, industry associations & experts, research institutes, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. Global Sepsis Diagnostics Market Research and Analysis by Product Type
2. Global Sepsis Diagnostics Market Research and Analysis by Technology
3. Global Sepsis Diagnostics Market Research and Analysis by Pathogen

The Report Covers
  • Comprehensive research methodology of the global Sepsis Diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Sepsis Diagnostics market.
  • Insights about market determinants which are stimulating the global Sepsis Diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of the market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Strategy Analysis
3.2. Key Company Analysis
3.2.1. bioMérieux SA
3.2.1.1. Overview
3.2.1.2. Financial Analysis
3.2.1.3. SWOT Analysis
3.2.1.4. Recent Developments
3.2.2. Becton, Dickinson, & Company
3.2.2.1. Overview
3.2.2.2. Financial Analysis
3.2.2.3. SWOT Analysis
3.2.2.4. Recent Developments
3.2.3. Thermo Fisher Scientific, Inc.
3.2.3.1. Overview
3.2.3.2. Financial Analysis
3.2.3.3. SWOT Analysis
3.2.3.4. Recent Developments
3.2.4. F. Hoffmann-La Roche Ltd.
3.2.4.1. Overview
3.2.4.2. Financial Analysis
3.2.4.3. SWOT Analysis
3.2.4.4. Recent Developments
3.2.5. Abbott Laboratories Inc.
3.2.5.1. Overview
3.2.5.2. Financial Analysis
3.2.5.3. SWOT Analysis
3.2.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Sepsis Diagnostics Market by Product Type
5.1.1. Instruments
5.1.2. Assays and Reagents
5.1.3. Others
5.2. Global Sepsis Diagnostics Market by Technology
5.2.1. Molecular Diagnostics
5.2.2. Immunoassay
5.2.3. Others (Flow Cytometry)
5.3. Global Sepsis Diagnostics Market by Pathogen
5.3.1. Bacterial Sepsis Diagnostics
5.3.2. Fungal Sepsis Diagnostics
5.3.3. Others
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Abionic SA
7.3. Accelerate Diagnostics, Inc.
7.4. Becton, Dickinson & Co.
7.5. Biomérieux SA
7.6. Bruker Corp.
7.7. Cepheid Inc.
7.8. Danaher Corp.
7.9. EKF Diagnostics Holdings plc
7.10. F. Hoffmann-La Roche Ltd.
7.11. Immunexpress Inc.
7.12. Inflammatix, Inc.
7.13. Luminex Corp.
7.14. Nanomix, Inc.
7.15. Qiagen NV
7.16. Quidel Corp.
7.17. Seegene Inc.
7.18. Siemens AG
7.19. Sysmex Corp.
7.20. T2 Biosystems, Inc.
7.21. Thermo Fisher Scientific Inc.
7.22. Trinity Biotech Plc
LIST OF TABLES
1. GLOBAL SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
2. GLOBAL SEPSIS DIAGNOSTICS INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL SEPSIS DIAGNOSTICS ASSAYS AND REAGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL OTHER SEPSIS DIAGNOSTICS PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
5. GLOBAL SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
6. GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
7. GLOBAL IMMUNOASSAY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
8. GLOBAL OTHER TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
9. GLOBAL SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PATHOGEN, 2018-2025 ($ MILLION)
10. GLOBAL BACTERIAL SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
11. GLOBAL FUNGAL SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
12. GLOBAL OTHER PATHOGEN MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
13. GLOBAL SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
14. NORTH AMERICAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
15. NORTH AMERICAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
16. NORTH AMERICAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
17. NORTH AMERICAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PATHOGEN, 2018-2025 ($ MILLION)
18. EUROPEAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
19. EUROPEAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
20. EUROPEAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
21. EUROPEAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PATHOGEN, 2018-2025 ($ MILLION)
22. ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
23. ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
24. ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
25. ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PATHOGEN, 2018-2025 ($ MILLION)
26. REST OF THE WORLD SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
27. REST OF THE WORLD SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
28. REST OF THE WORLD SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PATHOGEN, 2018-2025 ($ MILLION)
LIST OF FIGURES
1. GLOBAL SEPSIS DIAGNOSTICS MARKET SHARE BY PRODUCT TYPE, 2018 VS 2025 (%)
2. GLOBAL SEPSIS DIAGNOSTICS MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
3. GLOBAL SEPSIS DIAGNOSTICS MARKET SHARE BY PATHOGEN, 2018 VS 2025 (%)
4. GLOBAL SEPSIS DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
5. US SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
6. CANADA SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
7. UK SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
8. FRANCE SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
9. GERMANY SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
10. ITALY SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
11. SPAIN SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
12. ROE SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
13. INDIA SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
14. CHINA SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
15. JAPAN SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
16. REST OF ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
17. REST OF THE WORLD SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Abionic SA
  • Accelerate Diagnostics, Inc.
  • Becton, Dickinson & Co.
  • Biomérieux SA
  • Bruker Corp.
  • Cepheid Inc.
  • Danaher Corp.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • Immunexpress Inc.
  • Inflammatix, Inc.
  • Luminex Corp.
  • Nanōmix, Inc.
  • Qiagen NV
  • Quidel Corp.
  • Seegene Inc.
  • Siemens AG
  • Sysmex Corp.
  • T2 Biosystems, Inc.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc